Pharmaceutical Industry


Why are health scandals not accidents?
Why can’t it change?
Since he was elected UMP senator for Vaucluse in September 2004, Dr. Alain MILON has gradually taken over the levers of everything related to health care in the Senate.

He became:
– Member of the Parliamentary Office for the Evaluation of Health Policies,
– Vice-President of the Social Affairs Committee,
– Member of the High Council for the Financing of Social Protection,
– Vice-President of the Mission of ‘Social Security Assessment and Control (MECSS).
In addition, he chairs, or plays the role of rapporteur, in numerous committees concerning health, access to vaccines or reimbursement of medicines.

But strangely and jointly, we also find it intimately linked to players in the pharmaceutical industry:
– From October 24, 2005, he presides over the “First Social Meetings of the Senate – devoted to health”. At the round table he leads we find Ms. Véronique France-Tarif the lobbyist of Pfizer.
– On September 13, 2007, Alain Milon and Jean-Marie Le Guen organize and chair the “2nd Parliamentary Mental Health Meetings” funded by the pharmaceutical cartel Janssen-cilg, Pfizer and Sanofi-Aventis.
– On September 14, 2009, the doctors of the pharmaceutical industry (gathered within the AMIPS association) invite several personalities to a conference in order to ensure that they are not forgotten in the HPST bill (Hospital, Patients, Health, Territories). Alain Milon leads a round table again in the presence of Ms. Véronique France-Tarif, the lobbyist of Pfizer. This symposium is organized, within the Palais du Luxembourg, by the firm [AEC Partners chaired by François Sarkozy.
– On October 16, 2012, we find Alain Milon invited to a meeting on “Personalized medicine” organized by Pfizer and coordinated by the lobbying firm “Euro Politic”

In addition, Alain Milon is a member of the board of directors of the “Fondation Fondamental” (focused on scientific research on mental illnesses) chaired by David de Rothschild and funded by the Dassault Group and the pharmaceutical laboratories Astra-Zeneca, Bristol-Myers -Squibb, Janssen-Cilag, Lilly, Lundbeck and Servier.

Given its key position in the field of health in the Senate and its strong links with the pharmaco-industrial complex, are we not entitled to ask the question “a little, a lot, passionately” of the conflict of interest?
In March 2010, after the scandal of the management of the H1N1 flu crisis by the UMP government of the time, the communist senator François Autain obtained the creation of a commission of inquiry on the role of the pharmaceutical companies in this affair . Although Autain was chairman of this commission, have you heard of sanctions against pharmaceutical companies? No ! It is normal, Dr. Milon had been appointed Rapporteur of this commission to empty it of any risk.
Another disturbing coincidence: since November 2012, Milon finds himself chairman of a senatorial commission of inquiry against the danger of sects in the health field.
Understand: “Senate commission of inquiry against the danger of alternative medicines for the pharmaceutical industry!”
As the questions posed by Mr Milon are entirely against the natural therapies and anti-vaccine movements, it is not difficult to guess that the measures to be proposed by this committee will be those of the pharmaco-industrial complex.